Search details
1.
Peroxisome proliferator activated receptor-γ agonist pioglitazone improves vascular and metabolic dysfunction in systemic lupus erythematosus.
Ann Rheum Dis
; 2022 Aug 01.
Article
in English
| MEDLINE | ID: mdl-35914929
2.
Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus.
Nat Commun
; 12(1): 3391, 2021 06 07.
Article
in English
| MEDLINE | ID: mdl-34099646
Results
1 -
2
de 2
1
Next >
>>